Treatment of precocious puberty in McCune-Albright syndrome

Pediatric Endocrinology Reviews

Volumn 4, Issue SUPPL. 4, 2007, Pages 419-422

  Mieszczak, Jakub ^a,b   Eugster, Erica A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

McCune Albright syndrome; Precocious puberty; Treatment

Indexed keywords

ANASTROZOLE; ANTIANDROGEN; ANTIESTROGEN; AROMATASE INHIBITOR; BICALUTAMIDE; DESLORELIN; FADROZOLE; FLUTAMIDE; GONADORELIN DERIVATIVE; LETROZOLE; LEUPRORELIN; SPIRONOLACTONE; TAMOXIFEN; TESTOLACTONE;

ABDOMINAL PAIN; ALBRIGHT SYNDROME; BONE MATURATION; CAFE AU LAIT SPOT; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYST; ENDOCRINE DISEASE; FOOT DISCOMFORT; FOOT DISEASE; GASTROINTESTINAL SYMPTOM; HAND DISCOMFORT; HAND DISEASE; HEADACHE; HUMAN; MEDICAL RESEARCH; MUSCLE WEAKNESS; OVARY DISEASE; OVARY VOLUME; PATIENT COMPLIANCE; PRECOCIOUS PUBERTY; REVIEW; SIDE EFFECT; SKIN PIGMENTATION; TREATMENT OUTCOME; TREATMENT PLANNING; UTERUS DISEASE; UTERUS VOLUME; VAGINA BLEEDING; VIRILIZATION;

FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; PUBERTY, PRECOCIOUS;

EID: 35148857217     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 1937;216:722-746
2. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325(24):1688-1695
3. Foster CM. Endocrine manifestations of McCune-Albright syndrome. The Endocrinologist 1993;3(5):359-364
4. Syed FA, Chalew SA. Ketoconazole treatment of gonadotropin independent precocious puberty in a girl with McCune-Albright syndrome: a preliminary report. J Pediatr Endocrinol Metab 1999;12(1):81-83
5. Janssen PA, Symoens JE. Hepatic reactions during ketoconazole treatment. Am J Med 1983;74:80-85
6. Eugster EA. Aromatase inhibitors in precocious puberty: rationale and experience to date. Treat Endocrinol 2004;3(3):141-151
7. Albers N, Jorgens S, Deiss S, Hauffa BP. McCune-Albright syndrome - the German experience. J Pediatr Endocrinol Metab 2002;15(Suppl 3):897-901
8. Pienkowski C, Lumbroso S, Bieth E, Sultan C, Rochiccioli P, Tauber M. Recurrent ovarian cyst and mutation of the Gs alpha gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome? Acta Pediatrica 1997;86(9):1019-1021
9. Foster CM, Feuillan P, Padmanabhan V, Pescovitz OH, Beitins IZ, Comite F, Shawker TH, Loriaux DL, Cutler Jr GB. Ovarian function in girls with McCune-Albright syndrome. Pediatr Res 1986;20(9):859-863
10. Shawker TH, Comite F, Rieth KG, Dwyer AJ, Cutler Jr GB, Loriaux DL. Ultrasound evaluation of female isosexual precocious puberty. J Ultrasound Med 1984;3(7):309-316
11. Wikiera B, Wawro J, Noczyska A. (Precocious puberty caused by McCune-Albright syndrome in a girl aged 6 years and 9 months). (Polish) Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2006;12(1):63-67
12. Feuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker T, Dwyer A, Malley JD, Barnes K, Loriaux DL, Cutler Jr GB. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med 1986;315(18):1115-1119
13. Feuillan PP, Jones J, Cutler Jr GB. Long-term testolactone therapy for precocious puberty in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 1993;77(3):647-651
14. Nunez SB, Calis K, Cutler Jr. GB, Jones J, Feuillan PP. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 2003;88(12):5730-5733
15. Feuillan P, Calis K, Hill S, Shawker T, Robey PG, Collins MT. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab (Epub 2007 April 3)
16. Mieszczak J, Lowe E, Plourde P, Eugster EA. Anastrozole treatment of precocious puberty in girls with McCune-Albright syndrome (abstract no. 751770). Pediatr Res; In Press
17. Eugster EA, Shankar R, Feezle LK, Pescovitz OH. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome. J Pediatr Endocrinol Metab 1999;12(5):681-686
18. Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, Pescovitz OH. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome; a multicenter trial. J Pediatr 2003;143(1):60-66
19. Eugster EA, Pescovitz OH. Advances in the treatment of precocious puberty. Expert Opin Investig Drugs 2001;10(9):1623-1630
20. Schmidt H, Kiess W. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue. J Pediatr Endocrinol Metab 1998;11:77-81
21. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long-term follow-up. JAMA 1986;256(21):2980-2984
22. Gesmundo R, Guana R, Valfre L, De Sanctis L, Matarazzo P, Marzari D, Lala R. Laparoscopic management of ovarian cysts in peripheral precocious puberty of McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006;19 (Suppl 2):571-575
23. Nabhan ZM, West KC, Eugster EA. Oophorectomy in McCune-Albright syndrome: a case of mistaken identity. J Pediatr Surg in Press
24. Ariazi EA, Lewis-Wambi JS, Gill SD, Pyle JR, Ariazi JL, Kim HR, Sharma CGN, Cordera F, Shupp HA, Li T, Jordan VC. Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant. J Steroid Biochem Mol Biol 2006;102:128-138
25. Wasniewska M, Matarazzo P, Weber G, Russo G, Zampolli M, Salzano G, Zirilli G, Bertelloni S. Clinical presentation of the McCune-Albright syndrome in males. J Pediatr Endocrinol Metab 2006;19:619-622
26. sα gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 2000;86(4):1778-1781
27. Wasniewska M, De Luca F, Bertelloni S, Matarazzo P, Weber G, Crisafulli G, Valenzise M, Lala R. Testicular microlithiasis: an unreported feature of McCune-Albright syndrome in males. J Pediatr 2004;145:670-672
28. Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler Jr GB. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med 1989;320(8):496-502
29. Feuillan P, Merke D, Leschek EW, Cutler Jr. GB. Use of aromatase inhibitors in precocious puberty. Endocr Relat Cancer 1999;6(2):303-306
30. Laue L, Jones J, Barnes KM, Cutler Jr GB. Treatment of familial male precocious puberty with spironolactone, testolactone and deslorelin. J Clin Endocrinol Metab 1993;76(1):151-155
31. Kreher N, Pescovitz OH, Delameter P, Tiupakov A, Hochberg Z. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr 2006;149:416-420